The authors discuss the California Institute for Regenerative Medicine's focus on state, national, and international regulatory policy issues impacting basic research and translational medicine.
CITATION STYLE
Lomax, G. P., DeWitt, N. D., Millan, M. T., & Feigal, E. G. (2014). How California Institute for Regenerative Medicine Research Programs Support Science and Regulatory Policy. Stem Cells Translational Medicine, 3(6), 673–674. https://doi.org/10.5966/sctm.2014-0069
Mendeley helps you to discover research relevant for your work.